US · Healthcare

Day One Biopharmaceuticals Inc (DAWN)

Biotechnology

Day One Biopharmaceuticals Inc (DAWN) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for DAWN

P/E ratio

18.00

Day One Biopharmaceuticals Inc (DAWN) — FAQ

What is DAWN's P/E ratio?

The price-to-earnings (P/E) ratio for Day One Biopharmaceuticals Inc (DAWN) is 18.00 (data as of 2026-03-24).

Does Day One Biopharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Day One Biopharmaceuticals Inc (DAWN). Check the MyAverix Finance app for the latest dividend data.

What sector is Day One Biopharmaceuticals Inc in?

Day One Biopharmaceuticals Inc (DAWN) is classified in the Healthcare sector (Biotechnology industry).

What exchange is DAWN listed on?

DAWN is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)